Hiv Surveillance Report 2007 Update
Download Hiv Surveillance Report 2007 Update full books in PDF, epub, and Kindle. Read online free Hiv Surveillance Report 2007 Update ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Author | : King K. Holmes |
Publisher | : World Bank Publications |
Total Pages | : 1027 |
Release | : 2017-11-06 |
Genre | : Medical |
ISBN | : 1464805253 |
Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings.
Author | : Institute of Medicine |
Publisher | : National Academies Press |
Total Pages | : 217 |
Release | : 2010-11-17 |
Genre | : Medical |
ISBN | : 030917712X |
The Social Security Administration (SSA) uses a screening tool called the Listing of Impairments to identify claimants who are so severely impaired that they cannot work at all and thus qualify for disability benefits. In this report, the Institute of Medicine (IOM) makes several recommendations for improving SSA's capacity for determining disability benefits more accurately and quickly using the HIV Infection Listings.
Author | : Institute of Medicine |
Publisher | : National Academies Press |
Total Pages | : 200 |
Release | : 2011-08-26 |
Genre | : Medical |
ISBN | : 0309212197 |
Chronic diseases are common and costly, yet they are also among the most preventable health problems. Comprehensive and accurate disease surveillance systems are needed to implement successful efforts which will reduce the burden of chronic diseases on the U.S. population. A number of sources of surveillance data-including population surveys, cohort studies, disease registries, administrative health data, and vital statistics-contribute critical information about chronic disease. But no central surveillance system provides the information needed to analyze how chronic disease impacts the U.S. population, to identify public health priorities, or to track the progress of preventive efforts. A Nationwide Framework for Surveillance of Cardiovascular and Chronic Lung Diseases outlines a conceptual framework for building a national chronic disease surveillance system focused primarily on cardiovascular and chronic lung diseases. This system should be capable of providing data on disparities in incidence and prevalence of the diseases by race, ethnicity, socioeconomic status, and geographic region, along with data on disease risk factors, clinical care delivery, and functional health outcomes. This coordinated surveillance system is needed to integrate and expand existing information across the multiple levels of decision making in order to generate actionable, timely knowledge for a range of stakeholders at the local, state or regional, and national levels. The recommendations presented in A Nationwide Framework for Surveillance of Cardiovascular and Chronic Lung Diseases focus on data collection, resource allocation, monitoring activities, and implementation. The report also recommends that systems evolve along with new knowledge about emerging risk factors, advancing technologies, and new understanding of the basis for disease. This report will inform decision-making among federal health agencies, especially the Department of Health and Human Services; public health and clinical practitioners; non-governmental organizations; and policy makers, among others.
Author | : World Health Organization |
Publisher | : WHO Regional Office Europe |
Total Pages | : 101 |
Release | : 2010-03-24 |
Genre | : Medical |
ISBN | : 9291738328 |
The annual AIDS epidemic update reports on the latest developments in the global AIDS epidemic. With maps and regional summaries, the 2009 edition provides the most recent estimates of the epidemic s scope and human toll and explores new trends in the epidemic's evolution.
Author | : Joint United Nations Programme on HIV/AIDS. |
Publisher | : World Health Organization |
Total Pages | : 62 |
Release | : 2007 |
Genre | : Health & Fitness |
ISBN | : 9789291736218 |
This annual update provides global and regional estimates of AIDS and its impact. It also reviews the most recent data available from countries and discusses HIV trends in countries around the world. UNAIDS and WHO, together with experts from national AIDS programs and research institutions, regularly review and update the estimates as improved knowledge about the epidemic becomes available. They also draw on advances made in the methods of deriving estimates.
Author | : Michael S. Saag |
Publisher | : Elsevier Health Sciences |
Total Pages | : 225 |
Release | : 2014-09-28 |
Genre | : Medical |
ISBN | : 0323323286 |
This first part of a 2-part issue of Infectious Disease Clinics, edited by Michael S. Saag, MD and Henry Masur, MD, is devoted to HIV/AIDS. This issue will cover global epidemiology; testing, staging, and evaluation; linkage to care, retention in care; antiretroviral therapy: current drugs, when to start, what to start, failure; update on opportunistic infections; HIV co-morbidities; and co-infection Hepatitis B and Hepatitis C.
Author | : Institute of Medicine |
Publisher | : National Academies Press |
Total Pages | : 252 |
Release | : 2010-04-23 |
Genre | : Medical |
ISBN | : 0309153689 |
The global epidemic of hepatitis B and C is a serious public health problem. Hepatitis B and C are the major causes of chronic liver disease and liver cancer in the world. In the next 10 years, 150,000 people in the United States will die from liver disease or liver cancer associated with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections. Today, between 800,000 and 1.4 million people in the United States have chronic hepatitis B and between 2.7 and 3.9 million have chronic hepatitis C. People most at risk for hepatitis B and C often are the least likely to have access to medical services. Reducing the rates of illness and death associated with these diseases will require greater awareness and knowledge among health care workers, improved identification of at-risk people, and improved access to medical care. Hepatitis B is a vaccine-preventable disease. Although federal public health officials recommend that all newborns, children, and at-risk adults receive the vaccine, about 46,000 new acute cases of the HBV infection emerge each year, including 1,000 in infants who acquire the infection during birth from their HBV-positive mothers. Unfortunately, there is no vaccine for hepatitis C, which is transmitted by direct exposure to infectious blood. Hepatitis and Liver Cancer identifies missed opportunities related to the prevention and control of HBV and HCV infections. The book presents ways to reduce the numbers of new HBV and HCV infections and the morbidity and mortality related to chronic viral hepatitis. It identifies priorities for research, policy, and action geared toward federal, state, and local public health officials, stakeholder, and advocacy groups and professional organizations.
Author | : Stephen Inrig |
Publisher | : Univ of North Carolina Press |
Total Pages | : 226 |
Release | : 2011 |
Genre | : Medical |
ISBN | : 080783498X |
Thirty years after AIDS was first recognized, the American South constitutes the epicenter of the United States' epidemic. Southern states claim the highest rates of new infections, the most AIDS-related deaths, and the largest number of adults and adoles
Author | : Jonathan Cohen |
Publisher | : Elsevier Health Sciences |
Total Pages | : 1283 |
Release | : 2016-06-10 |
Genre | : Medical |
ISBN | : 070206338X |
Drs. Cohen, Powderly and Opal, three of the most-respected names in infectious disease medicine, lead a diverse team of international contributors to bring you the latest knowledge and best practices. Extensively updated, the fourth edition includes brand-new information on advances in diagnosis of infection; Hepatitis C; managing resistant bacterial infections; and many other timely topics. An abundance of photographs and illustrations; a practical, clinically-focused style; highly-templated organization; and robust interactive content combine to make this clinician-friendly resource the fastest and best place to find all of the authoritative, current information you need. - Hundreds of full-color photographs and figures provide unparalleled visual guidance. - Consistent chapter organization and colorful layouts make for quick searches. - Clinically-focused guidance from "Practice Points" demonstrates how to diagnose and treat complicated problems encountered in practice. - The "Syndromes by Body System", "HIV and AIDS", and "International Medicine" sections are designed to reflect how practicing specialists think when faced with a patient. - Sweeping updates include new or revised chapters on: - Hepatitis C and antivirals - Fungal infection and newer antifungals - Microbiome and infectious diseases as well as advances in diagnosis of infection; Clostridium difficile epidemiology; infection control in the ICU setting; Chlamydia trachomatis infection; acquired syndromes associated with autoantibodies to cytokines;; management of multidrug resistant pathogens; probiotics, polymyxins, and the pathway to developing new antibiotics - HIV including HIV and aging, antiretroviral therapy in developing countries, and cure for HIV. - Online Antimicrobial pharmacokinetics mannequin, as well an all new HIV medicine mannequin are a useful visual source of treatment information
Author | : Nkuchia M. M'ikanatha |
Publisher | : John Wiley & Sons |
Total Pages | : 1139 |
Release | : 2013-03-11 |
Genre | : Medical |
ISBN | : 1118543521 |
This fully updated edition of Infectious Disease Surveillance is for frontline public health practitioners, epidemiologists, and clinical microbiologists who are engaged in communicable disease control. It is also a foundational text for trainees in public health, applied epidemiology, postgraduate medicine and nursing programs. The second edition portrays both the conceptual framework and practical aspects of infectious disease surveillance. It is a comprehensive resource designed to improve the tracking of infectious diseases and to serve as a starting point in the development of new surveillance systems. Infectious Disease Surveillance includes over 45 chapters from over 100 contributors, and topics organized into six sections based on major themes. Section One highlights the critical role surveillance plays in public health and it provides an overview of the current International Health Regulations (2005) in addition to successes and challenges in infectious disease eradication. Section Two describes surveillance systems based on logical program areas such as foodborne illnesses, vector-borne diseases, sexually transmitted diseases, viral hepatitis healthcare and transplantation associated infections. Attention is devoted to programs for monitoring unexplained deaths, agents of bioterrorism, mass gatherings, and disease associated with international travel. Sections Three and Four explore the uses of the Internet and wireless technologies to advance infectious disease surveillance in various settings with emphasis on best practices based on deployed systems. They also address molecular laboratory methods, and statistical and geospatial analysis, and evaluation of systems for early epidemic detection. Sections Five and Six discuss legal and ethical considerations, communication strategies and applied epidemiology-training programs. The rest of the chapters offer public-private partnerships, as well lessons from the 2009-2010 H1N1 influenza pandemic and future directions for infectious disease surveillance.